Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 77771-461

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 77771-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Radha Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cls-tabs-25mg-100mg-container-label-100s (Cls Tabs 25mg 100mg Container Label 100s)

This is a description for Carbidopa and Levodopa Extended-Release Tablets, USP. The tablets are to be swallowed whole without chewing or cutting. They should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F). The medication is packaged in a high-resistant container and must be kept out of reach of children. Manufactured by ScieGen Pharmaceuticals, Inc. and distributed by Radhe Pharmaceutical, Inc. Each package contains 100 tablets.*

FDA Label Image

Cls-tabs-50mg-200mg-container-label-100s (Cls Tabs 50mg 200mg Container Label 100s)

FDA Label Image

Carbidopa Chemical Structure (Cls Tabs Carbi Str)

FDA Label Image

Levodopa Chemical Structure (Cls Tabs Levo Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.